Laplace Interventional ™ is developing a prosthetic valve to treat Tricuspid Regurgitation (TR) that is delivered through a ...

Minimally invasive treatment expands options for patients with severe heart valve leakage in FloridaNaples, Fla., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Naples Comprehensive Health (NCH) has performed the ...

A new study into the causes of leakage in one of the heart's most complex valve structures could lead to improved diagnosis and treatment of the condition. An estimated 1.6 million Americans suffer ...

The PASCAL Precision device is indicated to treat individuals with symptomatic severe tricuspid regurgitation.

Edwards’ approval should “strengthen the company’s position in the large and underpenetrated transcatheter tricuspid market,” ...

With the introduction of percutaneous options, the role of surgery in the repair of dysfunctional tricuspid valves is being reevaluated in an effort to reduce the risk for end-stage disease. In the ...

The Pascal system has been approved by the US Food and Drug Administration for transcatheter edge-to-edge tricuspid valve ...

Newswise — LOS ANGELES (Feb. 13, 2025) -- People living with tricuspid valve disease are gaining more treatment options, driven by research from Cedars-Sinai investigators and collaborators at other ...

Adults undergoing mitral valve surgery who have less than severe leakage of the tricuspid valve may benefit by having both valves repaired at the same time, including a decreased chance of severe ...

Tricuspid valve regurgitation occurs when blood abnormally flows backwards from the right ventricle into the right atrium through a diseased tricuspid valve. Tricuspid regurgitation can be organic ...

Tricuspid regurgitation, often overlooked, can lead to serious complications. Learn about its symptoms, causes, and why early ...

The FDA's approval in tricuspid regurgitation adds the clip-based Pascal Precision alongside Edwards’ Evoque implant for replacing the valve.